Actively Recruiting
Adenosine vs Diltiazem for Treatment of SVT in the ED
Led by Anne E. Zepeski · Updated on 2025-09-11
20
Participants Needed
1
Research Sites
69 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a small, pilot study with a primary goal of assessing patient perceptions of two medication treatments for supraventricular tachycardia in adult patients treated in the Emergency Department.
CONDITIONS
Official Title
Adenosine vs Diltiazem for Treatment of SVT in the ED
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients 18 years and older
- Diagnosis of acute, stable supraventricular tachycardia (SVT) in the emergency department
You will not qualify if you...
- Received intravenous AV-nodal blocking agents before study enrollment (including adenosine, non-dihydropyridine calcium channel blockers, beta-antagonists)
- History of Wolff-Parkinson-White (WPW) syndrome
- History of heart failure with reduced ejection fraction (LVEF ≤ 40%)
- Severe bronchoconstrictive lung disease
- Prior hypersensitivity to study medication
- Previously enrolled in this pilot study
- Pregnancy
- Incarceration
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Iowa Health Care
Iowa City, Iowa, United States, 52242
Actively Recruiting
Research Team
A
Anne Zepeski, PharmD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here